BOSTON–Digital Health Corp. has acquired Constant Therapy, a privately held developer of mobile solutions that was founded by Veera Anantha, the company said in a statement. Terms of the acquisition were not disclosed. Constant Therapy’s mobile solutions are aimed at treating patients with traumatic brain injury, stroke, aphasia, and learning disorders.
“We are delighted to join Digital Health Corp; its mission of helping patients get better at home resonates completely with the values, culture and products we have developed at Constant Therapy,” said Anantha.
Constant Therapy designs mobile applications for continuous and customizable therapy for people with speech, language, cognition, memory, and learning disorders. Born out of groundbreaking research at Professor Swathi Kiran’s laboratory at Boston University, the company’s comprehensive set of tools are in use at nationally recognized rehabilitation institutions for stroke survivors, victims of traumatic brain injury (TBI), people struggling with aphasia or dementia, and children who need special education and care due to learning disabilities.
With 65 task categories and a growing library of over 100,000 exercises, patients can augment their in-clinic therapy sessions on their own time, in the safety and comfort of their own homes, and continue to progress through the exercises in-between clinic visits or after in-clinic therapy has finished.
“Research has proven that brain injury and stroke survivors can push past a supposed ‘progress plateau’ and improve with effective and continuous brain rehabilitation. Constant Therapy’s on-demand and easy-to-use technology, based on extensive clinical research and thousands of active users, helps these patients and others with less severe cognitive disorders, continue to make progress at home, on their schedules,” said Dr. Joseph (Joe) Smith, MD, PhD, President and CEO of Digital Health Corp. “This technology is a perfect strategic complement to Digital Health Corp’s growing portfolio of patient recovery and rehabilitation solutions that provide evidence-based and affordable therapy options to help patients get better in the comfort and convenience of their own homes.”
Dr. Smith added: “We are excited to build upon Constant Therapy’s early-stage success by expanding and enhancing its speech language therapy programs. These enhancements will be supported by the continued development of a compelling, deep, and rich body of clinical evidence under the new The Learning Corp brand name that is unparalleled in this space.”
The company’s technologies, marketed under the Constant Therapy and NeuroPerformance Engine™ brands, are currently available in the U.S. with expansion to other markets planned for 2018 and beyond, pending country-specific regulations.
